The Latest Breaking News from Pfizer

As Hong Kong’s outbreak became the deadliest in the world, among the aid Beijing sent to the financial hub were 1 million packets of honeysuckle, rhubarb root, sweet wormwood herb and other natural ingredients, all mixed according to principles of traditional Chinese medicine.

Right-wing anti-vax activist Dr. Sherri Tenpenny was ridiculed for her statements

Parents and other carers now able to book lower-dose appointments for Monday onwards

In this week’s newsletter: after days of bad tweets and red carpet reactions, here’s the last word on the biggest Oscars moment of the decade

According to a US-based study, children ages 5 to 11 who received the Pfizer Inc (NYSE:PFE) / BioNTech SE's (NASDAQ:BNTX) COVID-19 vaccine were 68% less likely to be hospitalized during the omicron wave than unvaccinated children. Adolescents aged 12-18 who received two shots of the vaccine were around 40% less likely to be hospitalized with the…

A UCLA professor’s long-term coexistence plan won’t help and could hinder Shanghai’s response to the current crisis, a Zhejiang University professor argues

As governments prepare to live with COVID-19, some are questioning how much to rely on drugmakers to adapt vaccines to ward off future virus variants amid signs of tension between companies and regulators over the best approach, according to several sources familiar with the matter.

Pressure is increasing on the administration to go after drug patents.

The authorization for another booster arrives just as BA.2 becomes the dominant strain in the U.S.

Amid worst Covid-19 outbreak, city could turn pandemic into manageable endemic disease using self-isolation, self-testing and advanced drugs and vaccines

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait